Summary
Updated Aug 31, 2026
Dawn Svoronos files SEC Form 4 reports at Xenon Pharmaceuticals Inc. (XENE). 1 SEC Form 4 filing on record, dated 4 June 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Dawn Svoronos has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Dawn Svoronos go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Dawn Svoronos files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ian Mortimer - $21.30M of XENE open-market activity in the last 12 months
- Steven Gannon - $641K of XENE open-market activity in the last 12 months
- Christopher John Kenney - $244K of XENE open-market activity in the last 12 months
- Andrea Difabio - $231K of XENE open-market activity in the last 12 months
- Gary Patou - $70K of XENE open-market activity in the last 12 months
- Gillian Cannon - $63K of XENE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Dawn Svoronos?
Dawn Svoronos is a corporate insider of Xenon Pharmaceuticals Inc. (XENE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Dawn Svoronos submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Dawn Svoronos's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Dawn Svoronos and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial